Takeda Pharmaceutical Company Limited 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-10 06:10 am Sale | 2024-04-09 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,790,480 4.800% | -362,737 (-11.50%) | Filing |
| 2024-04-01 06:15 am Sale | 2024-03-28 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,153,217 5.400% | -602,366 (-16.04%) | Filing |
| 2024-01-25 06:11 am Sale | 2024-01-24 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,755,583 6.600% | -3,703,721 (-49.65%) | Filing |
| 2021-11-12 06:03 am Sale | 2021-11-09 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 7,459,304 19.200% | -1,212,696 (-13.98%) | Filing |